口服核苷聚合酶抑制剂(RG7128)和达诺韦联合治疗慢性丙型肝炎基因1型感染(INFORM-1):一项随机、双盲、安慰剂对照、剂量递增试验

{"title":"口服核苷聚合酶抑制剂(RG7128)和达诺韦联合治疗慢性丙型肝炎基因1型感染(INFORM-1):一项随机、双盲、安慰剂对照、剂量递增试验","authors":"D. Harnois","doi":"10.1016/J.YGAS.2011.07.125","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":23790,"journal":{"name":"Yearbook of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"139","resultStr":"{\"title\":\"Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial\",\"authors\":\"D. Harnois\",\"doi\":\"10.1016/J.YGAS.2011.07.125\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":23790,\"journal\":{\"name\":\"Yearbook of Gastroenterology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2011-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"139\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Yearbook of Gastroenterology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/J.YGAS.2011.07.125\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Yearbook of Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/J.YGAS.2011.07.125","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}